Risk factor
Negligible price volatility
Profitability factor
Strong growth
About
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs and other healthcare-related products. This segment also provides practice management, technology, clinical support, and business solutions...
Company Valuation
Based on key historical and expected multiples, the stock is fairly valued relative to its peers. In particular, the stock is reasonably priced on P/E, 'expensive' on EV/
Target Price
The average target price of MCK is 1061 and suggests 12% upside potential. Usually, this means a HOLD recommendation among investment firms. This neutral recommendation s
Buy
Sell